Lipidor Ab
Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, AKP-03 for bacterial skin diseases, and AKP-07 for atopic dermat… Read more
Market Cap & Net Worth: Lipidor Ab (LIPI)
Lipidor Ab (ST:LIPI) has a market capitalization of $15.59 Million (Skr174.88 Million) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #27809 globally and #380 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lipidor Ab's stock price Skr0.22 by its total outstanding shares 813404032 (813.40 Million).
Lipidor Ab Market Cap History: 2019 to 2025
Lipidor Ab's market capitalization history from 2019 to 2025. Data shows change from $1.19 Billion to $15.59 Million (-45.42% CAGR).
Index Memberships
Lipidor Ab is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$4.81 Billion | 0.24% | #86 of 281 |
Weight: Lipidor Ab's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Lipidor Ab Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lipidor Ab's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1103.16x
Lipidor Ab's market cap is 1103.16 times its annual revenue
0.84x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.19 Billion | $72.00K | -$13.81 Million | 16576.11x | N/A |
| 2020 | $978.13 Million | $620.00K | -$16.20 Million | 1577.63x | N/A |
| 2021 | $601.82 Million | $15.38 Million | -$21.20 Million | 39.14x | N/A |
| 2022 | $53.37 Million | $45.00K | -$41.29 Million | 1185.91x | N/A |
| 2023 | $36.54 Million | $78.00K | -$11.48 Million | 468.51x | N/A |
| 2024 | $15.44 Million | $14.00K | -$13.81 Million | 1103.16x | N/A |
Competitor Companies of LIPI by Market Capitalization
Companies near Lipidor Ab in the global market cap rankings as of March 18, 2026.
Key companies related to Lipidor Ab by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Lipidor Ab Historical Marketcap From 2019 to 2025
Between 2019 and today, Lipidor Ab's market cap moved from $1.19 Billion to $ 15.59 Million, with a yearly change of -45.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | Skr15.59 Million | +0.94% |
| 2024 | Skr15.44 Million | -57.74% |
| 2023 | Skr36.54 Million | -31.52% |
| 2022 | Skr53.37 Million | -91.13% |
| 2021 | Skr601.82 Million | -38.47% |
| 2020 | Skr978.13 Million | -18.04% |
| 2019 | Skr1.19 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Lipidor Ab was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.59 Million USD |
| MoneyControl | $15.59 Million USD |
| MarketWatch | $15.59 Million USD |
| marketcap.company | $15.59 Million USD |
| Reuters | $15.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.